Variant "KCNE1:c.121A>G(p.Ser41Gly)"
Search results: 2 records
Variant information
Gene:
Variant:
KCNE1:c.121A>G(p.Ser41Gly) 
Genomic location:
chr21:35821821(hg19) 
HGVS:
SO Term RefSeq
protein_coding NM_001330065.1:c.121A>G(p.Ser41Gly)
protein_coding NM_000219.5:c.112A>G(p.Ser38Gly)
protein_coding NM_001127670.3:c.112A>G(p.Ser38Gly)
protein_coding NM_001127668.3:c.112A>G(p.Ser38Gly)
protein_coding NM_001127669.3:c.112A>G(p.Ser38Gly)
protein_coding NM_001270405.2:c.112A>G(p.Ser38Gly)
protein_coding NM_001270403.2:c.112A>G(p.Ser38Gly)
protein_coding NM_001270402.2:c.112A>G(p.Ser38Gly)
protein_coding NM_001270404.2:c.112A>G(p.Ser38Gly)
show all
Alias:
KCNE1:S38G 
dbSNP ID:
GWAS trait:
no data 
Modifier statisitcs
Record:
Disorder:
Reference:
Effect type:
Expressivity(2)  
Modifier effect:
Altered severity(1) ,Risk factor(1)  
Details:
  • Target disease:
    Arrhythmia (HP:0011675)
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    This genetic variance may contribute as a second genetic modifier for arrhythmia development is under current investigation.
    Alias in reference:
    KCNE1:S38G
    Reference:
    Title:
    Susceptibility genes and modifiers for cardiac arrhythmias.
    Species studied:
    Human
    Abstract:
    The last decade has seen a dramatic increase in the understanding of the molecular basis of arrhythmias. Much of this new information has been driven by genetic studies that focused on rare, monogenic arrhythmia syndromes that were accompanied or followed by cellular electrophysiological or biochemical studies. The marked clinical heterogeneity known from these familial arrhythmia syndromes has led to the development of a multifactorial (multi-hit) concept of arrhythmogenesis in which causal gene mutations have a major effect on disease expression that is further modified by other factors such as age, gender, sympathetic tone, and environmental triggers. Systematic genetic studies have unraveled an unexpected DNA sequence variance in these arrhythmia genes that has ethnic-specific patterns. Whether this genetic variance may contribute as a second genetic modifier for arrhythmia development is under current investigation. The aim of this article is to review common genetic variation in ion channel genes and to compare these recent findings.
  • Target disease:
    Long QT Syndrome (DOID_2843)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered severity 
    Evidence:
    Pedigree analysis and gene activity study 
    Effect:
    KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers.
    Alias in reference:
    KCNE1:c.121A>G(p.Ser41Gly)
    Reference:
    Title:
    Allelic Complexity in Long QT Syndrome: A Family-Case Study.
    Species studied:
    Human
    Abstract:
    Congenital long QT syndrome (LQTS) is associated with high genetic and allelic heterogeneity. In some cases, more than one genetic variant is identified in the same (compound heterozygosity) or different (digenic heterozygosity) genes, and subjects with multiple pathogenic mutations may have a more severe disease. Standard-of-care clinical genetic testing for this and other arrhythmia susceptibility syndromes improves the identification of complex genotypes. Therefore, it is important to distinguish between pathogenic mutations and benign rare variants. We identified four genetic variants (KCNQ1-p.R583H, KCNH2-p.C108Y, KCNH2-p.K897T, and KCNE1-p.G38S) in an LQTS family. On the basis of in silico analysis, clinical data from our family, and the evidence from previous studies, we analyzed two mutated channels, KCNQ1-p.R583H and KCNH2-p.C108Y, using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant, encoded a non-functional channel that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel KCNH2-C108Y variant can be a pathogenic LQTS mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers.